---
figid: PMC2882741__1643fig3
figlink: /pmc/articles/PMC2882741/figure/fig3/
number: Fig. 3
caption: Disorders of GSL and ganglioside degradation. Inherited diseases (violet)
  caused by genetic defects of individual hydrolases/proteins (green) in the GSL and
  ganglioside degradation pathway. Increased levels of lysosphingolipids occur in
  the GSL LSDs, e.g., glucosylsphingosine in Gaucher disease, Lyso-Gb3 in Fabry disease,
  and galactosylsphingosine in Krabbe disease. Variant AB is GM2 activator deficiency
  disease. Tay-Sach disease, Sandhoff disease, and Variant AB are GM2 gangliosidosis.
  Abbreviations are listed in  legend.
pmcid: PMC2882741
papertitle: Multi-system disorders of glycosphingolipid and ganglioside metabolism.
reftext: You-Hai Xu, et al. J Lipid Res. 2010 Jul;51(7):1643-1675.
pmc_ranked_result_index: '37277'
pathway_score: 0.8065937
filename: 1643fig3.jpg
figtitle: Disorders of GSL and ganglioside degradation
year: '2010'
organisms: Homo sapiens
ndex: f28d43f3-de9c-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2882741__1643fig3.html
  '@type': Dataset
  description: Disorders of GSL and ganglioside degradation. Inherited diseases (violet)
    caused by genetic defects of individual hydrolases/proteins (green) in the GSL
    and ganglioside degradation pathway. Increased levels of lysosphingolipids occur
    in the GSL LSDs, e.g., glucosylsphingosine in Gaucher disease, Lyso-Gb3 in Fabry
    disease, and galactosylsphingosine in Krabbe disease. Variant AB is GM2 activator
    deficiency disease. Tay-Sach disease, Sandhoff disease, and Variant AB are GM2
    gangliosidosis. Abbreviations are listed in  legend.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ETFA
  - ADCY10
  - ADCY4
  - ADCY2
  - GLA
  - ADCY9
  - ADCY5
  - ADCY6
  - ADCY8
  - ADCY1
  - ADCY3
  - GALC
  - ADCY7
  - Lactosylsphingosine
  - Glucosylsphingosine
  - Ceramide
  - Di-Galactosylceramide
  - Glucosylceramide
  - Lactosylceramide
  - Galactosylsphingosine
  - Sphingomyelin
  - Sphingosine
  - Sulfatide
genes:
- word: GA2
  symbol: GA2
  source: hgnc_alias_symbol
  hgnc_symbol: ETFA
  entrez: '2108'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: GLA
  symbol: GLA
  source: hgnc_symbol
  hgnc_symbol: GLA
  entrez: '2717'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: GALC,
  symbol: GALC
  source: hgnc_symbol
  hgnc_symbol: GALC
  entrez: '2581'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
chemicals:
- word: Lactosylsphingosine
  source: MESH
  identifier: C023601
- word: Glucosylsphingosine
  source: MESH
  identifier: C035742
- word: Ceramide
  source: MESH
  identifier: D002518
- word: Di-Galactosylceramide
  source: MESH
  identifier: D005699
- word: Glucosylceramide
  source: MESH
  identifier: D005963
- word: Lactosylceramide
  source: MESH
  identifier: D007790
- word: Galactosylsphingosine
  source: MESH
  identifier: D011609
- word: Sphingomyelin
  source: MESH
  identifier: D013109
- word: Sphingosine
  source: MESH
  identifier: D013110
- word: Sulfatide
  source: MESH
  identifier: D013433
diseases: []
---
